# Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.

> **NCT03569917** · NA · TERMINATED · sponsor: **Nantes University Hospital** · enrollment: 143 (actual)

## Conditions studied

- Patients Receiving Ceftriaxone in Hospital Emergency Unit

## Interventions

- **OTHER:** Rectal swab collection

## Key facts

- **NCT ID:** NCT03569917
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-12-19
- **Primary completion:** 2022-09-19
- **Final completion:** 2022-09-19
- **Target enrollment:** 143 (ACTUAL)
- **Why stopped:** 143 patients have been recruited instead of 150 but the theoretical date of end of inclusions being reached, we have decided to not prolong again the study.
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03569917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03569917, "Identification of Gut Microbiome Biomarkers Associated to Acquisition of Enterobacteriae Highly Resistant to Third Generation Cephalosporines Following Ceftriaxone Treatment.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03569917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*